White v. Vertex Pharmaceuticals

District Court, E.D. Missouri·Decided August 3, 2020·No. 1:20-cv-00059·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI SOUTHEASTERN DIVISION

MARY L. WHITE, ) ) Plaintiff, ) ) v. ) Case No. 1:20-cv-59-SNLJ ) VERTEX PHARMACEUTICALS and ) DR. EDWARDO D. VERZOLA, ) ) Defendants. )

MEMORANDUM AND ORDER This matter is before the Court upon the filing of the amended complaint by self- represented plaintiff Mary L. White. (ECF No. 5). The Court previously granted plaintiff in forma pauperis status and reviewed her complaint under 28 U.S.C. § 1915. (ECF No. 4). Based on that review, the Court directed plaintiff to file an amended complaint in compliance with the Court’s instructions. For the reasons discussed below, the Court will dismiss plaintiff’s claims against defendants Vertex Pharmaceuticals and Dr. Edwardo D. Verzola pursuant to 28 U.S.C. § 1915 for failing to state a claim upon which relief may be granted. The Complaint On March 20, 2020, self-represented plaintiff Mary L. White filed this civil suit on a Court- provided form against defendant Vertex Pharmaceuticals (“Vertex”).1 Plaintiff alleged that in 2012 she was prescribed a “triple therapy” medication regimen which included “Incivek,

1 On February 20, 2020, plaintiff filed two separate complaints against Dr. Eduardo D. Verzola and Genentech-Roche Pharmaceutical, respectively. See White v. Verzola, 4:20-cv-295-RLW (E.D. Mo.) and White v. Genentech-Roche Pharmaceutical, 1:20-cv-41-RLW (E.D. Mo.). These two cases share similar facts and allegations with the instant action. White v. Verzola was dismissed on July 21, 2020 for lack of subject matter jurisdiction. As of the date of this Order, White v. Genentech-Roche Pharmaceutical remains pending. Peginterferon alfa, and ribavirin combination” for treatment of her Hepatitis C. (ECF No. 1 at 5). Plaintiff stated that the medication caused a “serious skin reaction that covered the entire body, mental stress, fatigue, anxiety, [and] loss of memory.” (Id.) Plaintiff alleged that the “manufacturer failed to warn the public of the dangerous side effect[s].” (Id.)

For relief, plaintiff requested the Court to award her $2,000,000 in actual damages; $1,500,000 for mental stress, anxiety, and loss of memory; $500,000 for loss of employment; and “all medical bills to be paid for the rest of [her] life.” (Id. at 5-6). Plaintiff also asked the Court to compensate an unknown individual, James R. Ward, $500,000 for “his lost will.” On July 13, 2020, the Court reviewed plaintiff’s complaint pursuant to 28 U.S.C. § 1915. (ECF No. 4). In liberally construing the complaint, the Court interpreted her allegations to assert a claim for product liability/failure to warn against Vertex. For the purpose of conducting pre- service review, the Court presumed it had diversity jurisdiction over the action as she asserted an amount in controversy that exceeded the jurisdictional threshold and established the diversity of the parties.

The Court determined, however, that plaintiff’s complaint was subject to dismissal. Specifically, the Court found the following deficiencies: (1) failure to allege facts permitting the reasonable inference that Vertex was the manufacturer of the drugs at issue; (2) failure to allege facts permitting the reasonable inference that the drugs were the proximate cause of her skin reactions, mental stress, fatigue, anxiety, and loss of memory, or that she used the drugs as directed by her physician and pharmacist; (3) failure to plead facts permitting the inference that Vertex did not adequately warn of the risk; and (4) failure to plead facts permitting the inference that this action is timely under Missouri’s five-year statute of limitations for product liability and personal

2 injury claims. As to the timeliness issue, the Court noted that her complaint was filed in this Court on March 20, 2020, eight years after she was allegedly prescribed the drugs at issue and began to experience negative reactions. Because plaintiff was self-represented, the Court entered an order giving her the

opportunity to file an amended complaint to cure the pleading deficiencies and address the apparent untimeliness of her lawsuit. In that order, the Court provided plaintiff with clear instructions about how to prepare her complaint. (ECF No. 4 at 6-7). Plaintiff was warned that the filing of an amended complaint would entirely replace the original complaint and, as a result, “must include all claims [she] wishes to bring.” (Id. at 6). Plaintiff has now filed an amended complaint, which the Court reviews pursuant to 28 U.S.C. § 1915(e)(2). Legal Standard Under 28 U.S.C. § 1915(e), the Court is required to dismiss a complaint filed in forma pauperis if it is frivolous, malicious, or fails to state a claim upon which relief can be granted, or

seeks monetary relief against a defendant who is immune from such relief. To state a claim for relief, a complaint must plead more than “legal conclusions” and “[t]hreadbare recitals of the elements of a cause of action [that are] supported by mere conclusory statements.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). A plaintiff must demonstrate a plausible claim for relief, which is more than a “mere possibility of misconduct.” Id. at 679. “A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. at 678. Determining whether a complaint

3 states a plausible claim for relief is a context-specific task that requires the reviewing court to draw on its judicial experience and common sense. Id. at 679. When reviewing complaint filed by a self-represented person under 28 U.S.C. § 1915, the Court accepts the well-pled facts as true, White v. Clark, 750 F.2d 721, 722 (8th Cir. 1984), and

liberally construes the complaint. Erickson v. Pardus, 551 U.S. 89, 94 (2007); Haines v. Kerner, 404 U.S. 519, 520 (1972). A “liberal construction” means that if the essence of an allegation is discernible, the district court should construe the plaintiff’s complaint in a way that permits his or her claim to be considered within the proper legal framework. Solomon v. Petray, 795 F.3d 777, 787 (8th Cir. 2015). However, even self-represented complainants are required to allege facts which, if true, state a claim for relief as a matter of law. Martin v. Aubuchon, 623 F.2d 1282, 1286 (8th Cir. 1980). See also Stone v. Harry, 364 F.3d 912, 914-15 (8th Cir. 2004) (refusing to supply additional facts or to construct a legal theory for the self-represented plaintiff that assumed facts that had not been pleaded). The Amended Complaint

Free access — add to your briefcase to read the full text and ask questions with AI

White v. Vertex Pharmaceuticals, (E.D. Mo. 2020).

White v. Vertex Pharmaceuticals (White v. Vertex Pharmaceuticals) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Hanna v. Plumer
380 U.S. 460 (Supreme Court, 1965)
Haines v. Kerner
404 U.S. 519 (Supreme Court, 1972)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Great Plains Trust Co. v. Union Pacific Railroad
492 F.3d 986 (Eighth Circuit, 2007)
Johnson v. Medtronic, Inc.
365 S.W.3d 226 (Missouri Court of Appeals, 2012)
James Solomon v. Deputy U.S. Marshal Thomas
795 F.3d 777 (Eighth Circuit, 2015)
Manhattan Community Access Corp. v. Halleck
587 U.S. 802 (Supreme Court, 2019)
Martin v. Aubuchon
623 F.2d 1282 (Eighth Circuit, 1980)